Genes Guide L-Methylfolate Adjuvant Rx for Treatment-Resistant Depression
Genetic testing can be used to identify patients who would benefit from L-methylfolate adjunctive therapy with antidepressants.
Genetic testing can be used to identify patients who would benefit from L-methylfolate adjunctive therapy with antidepressants.
In an analysis of polygenic risk scores, the researchers identified significant overlap between anxiety and major depressive disorder, as well as PTSD.
Incremental diagnostic yield decreases substantially after 70 to 75 years; LS is rare after 80 years.
Performance of cfDNA test for trisomy 21 in twin pregnancies is similar to that in singleton pregnancies.
Risks related to DTC testing include lack of understanding of the test by the consumer, incorrect test results, and erroneous interpretation of the results.
Infants with X-linked severe combined immunodeficiency were found to have fully functioning immune systems following treatment with gene therapy.
Variants are associated with reproductive and metabolic traits in PCOS families.
Patients receiving GAD gene therapy develop unique treatment-dependent polysynaptic brain circuit.
Progesterone receptor levels as a biomarker may improve predictability of response to progestin-based therapy for endometriosis.
Genetic and lifestyle factors are independently associated with incident stroke among men and women aged 40 to 73 years.